RPG Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)
RPG Life Sciences Ltd · Outcome · 30 Oct 2026, 3:07 am
RPG Life Sciences Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 21,164 (+16.5% YoY | +8.2% QoQ) ■ EBITDA: 4,042 (+3.6% YoY | -7.3% QoQ) ■ EBITDA Margin (%): 19.1 (-238 bps YoY | -318 bps QoQ) ■ PAT: 2,660 (-27.8% YoY | -13.0% QoQ) ■ EPS (INR): 17.1 (-23.4% YoY | -7.7% QoQ)
Original exchange filing (PDF)
More announcements from RPG Life Sciences Ltd
- Earning call Transcript · 05 Nov 2026
- Audio Recording of Q2FY27 Results Earnings Call held on October 30, 2026 · 31 Oct 2026
- Investor Presentation · 30 Oct 2026
- Amendment to Policy on Related Party Transactions · 30 Oct 2026
- Press Release · 30 Oct 2026
- Outcome of Board Meeting held on October 29, 2026. · 30 Oct 2026
- Financial Result for the quarter ended September 30, 2026 · 30 Oct 2026
- Outcome of Board Meeting · 30 Oct 2026
